OBJECTIVE: To investigate the associations between indices of adiposity and cardiovascular risk factors in individuals with an atherogenic lipoprotein phenotype (ALP). SUBJECTS: Fifty-®ve men, aged 34 ± 69 y, body mass index (BMI) 22 ± 35 kgam 2 , with an ALP lipid pro®le (triglycerides (TG) 1.5 ± 4.0 mmolal, HDL`l.l mmolal; %LDL-3 b 40% total LDL). DESIGN: Each participant provided a fasting blood sample and underwent an 8 h postprandial assessment and had anthropometric measurements taken. OUTCOME MEASURES: BMI, waist circumference (W), waist-to-hip ratio (WaH), sum of skinfolds (SSK), fasting and postprandial concentrations of glucose, insulin and plasma lipids, post-heparin lipase activity, and apoE genotype. RESULTS: The expected positive associations between BMI, W and SSK and fasting and postprandial insulin were observed (r 0.42 ± 0.65). Little association between glucose responses and any measures of adiposity was evident. Unexpectedly, there were no positive associations between measures of central adiposity (W and WaH) and fasting and postprandial TG responses, with a trend towards negative associations in this study group (TG AUC vs W, r À À0.23, P 0.097; TG IAUC vs WaH, r À À0.26, P 0.068). Subgroup analysis indicated that lack of a positive association between central adiposity and postprandial TG values was more evident in those with one E4 allele (r À À0.42, P 0.077) relative to non-E4 carriers (r À À0.16, P 0.430). The expected positive associations between insulin and TG responses were not observed (r À À0.03 toÀ À0.36). CONCLUSION: In this ALP group the expected positive association between TG responses and a centralized distribution of body fat was not observed, particularly in individuals with an apoE4 genotype. Our ®ndings are not in line with the view that there is a clear causal relationship between insulin resistance and the lipid abnormalities associated with ALP.
Introduction
The atherogenic lipoprotein phenotype (ALP) was ®rst described in 1990. 1 It is a sub-clinical condition displaying a combined fasting dyslipidaemia, characterized by moderate hypertriglyceridaemia (1.5 ± 4.0 mmolal), low HDL-cholesterol levels (`1.1 mmolal) and a predominance of the`putatively' atherogenic small dense LDL-3 particles (b40% total LDL). 2 ± 4 The pathophysiological signi®cance of the ALP is clear in that it is considered to be the classical dyslipidaemia of Syndrome X (or the metabolic syndrome), 5 responsible in part for the excess risk of coronary heart disease (CHD) associated with diabetes and obesity. 6, 7 However, its signi®cance as a silent dyslipidaemia in apparently healthy subjects without diabetes or gross obesity may be even more important, given its reported prevalence of 25% in normal middle-aged men, 8 in whom there is a 3 ± 6 fold higher risk of CHD. 9 Despite the reported frequency of the ALP in middle-aged populations, a full understanding of its aetiology and the contribution of variations in body fat distribution and insulin resistance, diet, physical activity and genotype, is currently lacking. It has been proposed that a triglyceride (TG) intolerance, arising from resistance to the actions of insulin on hepatic and extra hepatic pathways of TG metabolism, is the core metabolic perturbation in subjects with an ALP. Raised circulating TG and accelerated neutral lipid exchange lead to the formation of the atherogenic small dense LDL and a reduction in circulating HDL levels. 10, 11 Much evidence for this comes from extrapolation of data from studies of subjects with non-insulin dependent diabetes mellitus (NIDDM) in whom a dyslipidaemia characteristic of an ALP is very frequently observed. 12, 13 However, it is unclear to what extent insulin resistance contributes to the raised triglycerides observed in subjects with an ALP in whom there is no evidence of abnormal glucose homeostasis.
Numerous population-based and case ± control studies carried out in both heterogeneous and more homogeneous populations, have consistently demonstrated a positive association between a centralized body fat topography and fasting and postprandial TG, 14 ± 18 insulin 19, 20 and glucose 20, 21 concentrations and negative associations with insulin sensitivity 20, 22, 23 and HDL-C concentrations. 17, 24, 25 Whilst it might be expected that similar relationships between centralized body fat distribution, insulin resistance and triglyceride concentrations would be observed in subjects with an ALP, there have been few studies which have examined this, either by means of a comparison of ALP subjects with an appropriate control group, or within an ALP group, by evaluation of associations between anthropometric measurements and lipid and insulin values.
We have recently recruited a group of middle-aged men with an ALP pro®le to participate in a dietary intervention study which will evaluate effects of long chain n-3 polyunsaturated fatty acids on triglyceride metabolism. As part of the baseline assessment a full anthropometric and metabolic evaluation was undertaken, including assessment of postprandial glucose, insulin, triglyceride and non-esteri®ed fatty-acid (NEFA) responses to a standard test meal protocol. Although they were recruited according to de®ned phenotypic criteria, the group as a whole demonstrated a range of baseline anthropometric and metabolic values. This has enabled us to address the question of the association between measures of body fat and body fat distribution and measures of insulin, insulin sensitivity, glucose, NEFA and triglyceride tolerance in a group of ALP subjects. Surprisingly, although the expected positive relationship between central adiposity and insulin response was observed, the predicted positive relationship between fasting and postprandial triglyceride levels and central adiposity was not observed in this group.
Because two recent studies have reported a lack of a positive association between abdominal obesity and lipaemia 26 and hyperinsulinaemia and hypertriglyceridaemia 27 in subjects with an apoE4 allele, we have studied the prevalence of apoE4 in this ALP group. Subgroup analysis was performed to evaluate the association between central adiposity and insulin and triglycerides responses in the ALP subjects according to apoE genotype. The data suggest that a higher than normal prevalence of the apoE4 allele in the ALP subjects may partly explain the relationships we have observed, but other factors also appear to be involved.
Subjects and materials

Subjects
Fifty-®ve healthy men aged 30 ± 70 y were recruited through the Department of Chemical Pathology, Royal Berkshire Hospital, Reading, UK, where all blood samples taken for lipid assessment in the West Berkshire Health District are analysed. Individuals with a lipid pro®le of TG 1.5 ± 4.0 mmolal, total cholesterol (TC) 5.0 ± 8.0 mmolal and HDL-cholesterol (HDL-C)`l.l mmolal were considered at risk of an ALP. These individuals were sent a letter via their general practitioner, giving brief details of the study. Those interested in participating attended the Human Nutrition Unit, University of Reading, and completed a health and lifestyle questionnaire, and provided a fasting blood sample in order to assess their fasting lipid and LDL pro®les in detail. Individuals who suffered from diabetes, liver or other endocrine dysfunction, malabsorption syndrome, anaemia, or had previously suffered a coronary event, were automatically excluded. Volunteers were required to be non-smokers, not on any hypolipidaemic or any other medication known to interfere with lipoprotein metabolism, consuming any fatty acid supplements, or on a weight reducing diet. The ®nal metabolic criteria for inclusion were; LDL-3b40% of total LDL, TG 1.5 ± 4.0 mmolal, TC 5.0 ± 8.0 mmolal, HDL-C`1.1 mmolal, glucosè 6.5 mmolal, haemoglobin b130 gal, BMI 20 ± 35 kgam 2 , blood pressure`160a95 mmHg. All volunteers who met these criteria were asked to participate in a full postprandial evaluation, including anthropometric assessment. The University of Reading Ethics Committee and the West Berkshire Health Authority Ethics Committee approved the study protocol, and each participant gave written consent. The blood lipid and anthropometric characteristics of the participants are given in Table 1 .
Methods
After a 12 h overnight fast, each participant completed a postprandial assessment. The previous day no alcohol or strenuous exercise was allowed and a set evening meal containing`20 g total fat was provided in order to standardize short-term fat intake. Prior to consuming the test meals, a cannula was inserted into the antecubital vein of the forearm and a fasting blood (30 ml) sample taken. A relatively high fat test breakfast (0 min) and lunch (330 min), providing 49 g and 31 g fat, and 109 g and 63 g carbohydrate, respectively, were consumed. Meal fat contents were not adjusted according to variations in body weight or body fat to prevent systematic bias. Blood samples were collected at 0, 30, 60, 90, 150, 210, 270, 330, 360, 390, 420 and 480 min. The blood samples (11 ml) were collected into a potassium EDTA-tube (10 ml), and a¯uoride oxalate tube (1 ml) for glucose analysis. At 480 min, l00 IUakg heparin was administered intravenously and a 5 ml blood sample collected 15 min later into lithium heparin tubes, for the determination of plasma postheparin lipoprotein lipase (LPL) activity. Blood samples were centrifuged at 1600 g for 10 min and subsamples of plasma collected for glucose, TC, TG, NEFA and insulin analysis. A 10 ml sample of fasting plasma was collected for LDL-3 analysis. Dextran sulphate and magnesium chloride were added to 1 ml of fasting plasma, to precipitate all the apolipoprotein B containing lipoproteins, to allow the determination of HDL-C. 28 All aliquots were stored at À20 C awaiting analysis, with the exception of the plasma collected for LPL activity, which was stored at À80 C, and the plasma collected for LDL-3 analysis, which was stored at 4 C and analysed within 24 h.
Anthropometric measurements
A single trained observer performed all anthropometric measurements. Participants were assessed wearing light clothing and without footwear. Height was measured to the nearest cm using an upright stadiometer and weight to the nearest 0.5 kg on a standard medical scales. Circumferences were assessed to within 1 mm in a standing position. Waist circumference was determined mid-way between the lowest rib margin and the iliac crest, and hip circumference at the widest point of the greater trochanters. Skinfold thickness was measured using a Harpenden's callipers at the triceps, biceps, subscapular and suprailiac sites as described previously. 29 Each individual measurement was taken to the nearest 1 mm and the mean skinfold thickness at each site calculated from three readings. The percentage CV (coef®cient of variance) for waist, hip and skinfold readings at the various sites was 2.3, 2.8 and 4 ± 5% respectively. Waist (W) and waist to hip ratio (WaH) were used as indices of a central fat distribution, whereas the sum of the skinfolds for the four sites (SSK) was used to assess total adipose tissue mass. Anthropometric data for the group are included in Table 1 .
Analytical procedures
Plasma samples were analysed for TG, TC, HDL-C and glucose using the Monarch Automatic Analyser (Instrumentation Laboratories Ltd, Warrington, UK) and enzymatic colorimetric kits (Instrumentation Laboratories Ltd). The mean intra-and inter-assay CVs for TG, TC, NEFA and glucose were 1.8, 2.0, 2.1 and 2.5%, and 3.2, 4.2, 4.1 and 4.9%, respectively. Immunologically active insulin was measured using a speci®c enzyme-linked immunosorbent assay kit (Dako Ltd, High Wycombe, UK) incorporating two monoclonal antibodies. 30 Intra-and inter-assay CVs of 3.0 and 4.0%, respectively, were observed. Insulin was only measured in half of the study group, chosen randomly. The glucose, insulin and TG responses were determined both as the total area under the curve (AUC) and the incremental area from the fasting value (IAUC), calculated by the trapezoidal rule.
Two indices of NEFA response were evaluated: (a) fasting NEFA; and (b) percentage NEFA suppression 90 min post-breakfast, which re¯ects the insulininduced inhibition of the release of fatty acids from TG stored in adipose tissue.
Glucose : insulin ratios were used as indices of insulin sensitivity to glucose utilization. LPL activity was measured in the 5 and 15 min post-heparin plasma samples. Total lipase activity was measured, with LPL activity being inhibited with 4 M sodium chloride by a modi®cation of the method described by Nilsson-Ehle et al. 31 The detection of the liberated 3H-labelled triolein substrate emulsion (Amersham International, Herts, UK) is used as an index of triolein hydrolysis. Enzyme activity was expressed in mU, where l mU represents nmol oleateaminaml plasma at 37 C. The inter-assay CVs for this method were 4.9% at 70 and 5.6% at 270 nmol oleateaminaml, and the inter-assay CV was 8.7% at 260 nmol oleateaminaml. LDL subclasses were separated by density-gradient ultracentrifugation and the relative percentage of small, dense LDL-3 calculated by integrating the respective area under the LDL subclass pro®le. The inter-and intra-assay CVs were`6.5% and 5.4% respectively, for LDL-3, as previously described in Grif®n et al.
32
DNA was extracted from 10 ml of blood, collected after an overnight fast into EDTA tubes. 33 ApoE genotyping was performed using the method of Bolla et al. 33 
Statistics
Results were expressed as mean (s.d.). The data were checked for normality and a logarithmic (log 10) transformation was performed where necessary. Simple linear correlations were used to quantify the Figure 2 the metabolic responses of the low ( 100 cm) and high (b100 cm) waist groups are compared using two-way ANOVA with time and waist size as the independent variables. Stepwise multiple regression was also performed, using a P-in of 0.05 and P-out of 0.10 in order to establish the independent associations between the metabolic variables, while adjusting for co-variates. In the current study, lipaemic, glycaemic, insulinaemic and NEFA responses to the standard meals and percentage LDL-3 in the fasted state, were the primary outcome variables of interest. Waist, BMI and SSK were the measures of adiposity included in the multiple regression analysis. The validity of the regression model was monitored by the study of residuals. A P-value`0.05 was considered signi®cant. All statistical analysis was performed on the SPSS statistical package (Version 6.1, Chicago, USA).
Results
No signi®cant associations were seen between fasting or postprandial glucose and any measure of adiposity, whether with or without adjustment for BMI ( Table  2) . As expected, consistent and statistically signi®cant positive associations were observed between both fasting and postprandial insulin responses and measures of adiposity (BMI, W, and subcutaneous fat (SSK)), although there was no association with WaH (Table 2, Figure la) . When values were adjusted for the effects of BMI, the associations no longer remained or tended to become negative.
Fasting and postprandial glucose:insulin ratios were examined as a measure of insulin sensitivity with respect to glucose disposal. Consistently negative associations between these variables and indices of adiposity were observed, which were statistically signi®cant except in the case of WaH (Table 2, Figure 1b) . When the correlations were corrected for the effect of BMI, little association between glucose:insulin ratios and W or SSk remained.
Less predictably, in the case of fasting and postprandial TG (AUC and IAUC), there was no association with BMI or SSk. However, consistent non-signi®cant negative associations between indices of TG tolerance and central adiposity (W and WaH) were observed (Table 2, Figure 1c ). In the case of TG AUC vs W, and TG IAUC vs WaH the values for the correlation coef®cients were r À0.23 (P 0.097) and r À0.26 (P 0.068), respectively. This trend towards a more favourable postprandial TG response with greater fat accumulation around the waist is further illustrated in Figure 2 . Although fasting TG levels were not signi®cantly different, overall postprandial TG response (TG AUC, P 0.000) and the incremental postprandial TG response (TG IAUC, P 0.000) were signi®cantly lower in the high waist circumference group (bl00 cm) compared to the low waist circumference group, particularly after the second meal. When the TG responses were corrected for BMI, in order to distinguish the contribution of central vs gross fat mass (Table 2) , the associations remained the same as in simple univariate analysis.
In the ALP group the associations between central adiposity and postprandial TG was compared in those with and without an apoE4 allele. As shown in Figure  3 , although not of statistical signi®cance, an apparent stronger negative association between central adiposity and TG AUC was evident in the apoE4 group (n 20; r À0.42, P 0.077; Figure 3b ) than in the non-E4 group (n 30; r À0.16, P 0.430; Figure  3a ) or in the group as a whole (n 50; r À0.23, P 0.097; Figure 1c) .
No signi®cant correlation between any measure of adiposity and percentage NEFA suppression (90 min), total-or HDL-C, or LPL activity was evident (Table  2) . However, when the associations were corrected for the effect of BMI, W and WaH emerged as signi®cant positive correlates of NEFA suppression.
Because elevated triglycerides have been suggested as the primary metabolic defect in the ALP, we were particularly interested in understanding the relation- ship between fasting and postprandial triglycerides and other metabolic variables in this ALP group (Table 3) . Percentage LDL-3 was strongly positively associated with all TG measurements, particularly fasting TG (r À0.61, P`0.001). A negative association between post-heparin plasma LPL activity and fasting TG (r À0.30, P`0.05) and TG AUC values (r À0.36, P`0.05) was observed. Although the correlation did not reach statistical signi®cance, also noteworthy is the possible negative association between percentage LDL-3 and post-heparin LPL activity (r À0.27, P 0.077; data not shown). Unexpectedly, the strong positive association between TG and insulin responses consistently observed in population-based studies were not observed in this ALP group.
Stepwise multiple regression was used to establish the independence of the associations observed in the univariate correlation analysis. The results are given in Table 4 . BMI, waist circumference and SSK were included as independent variables in all multiple BMI emerged as an independent determinant of fasting glucose, glucose AUC, fasting insulin, insulin AUC, fasting glucose:insulin ratio, and glucose:insulin AUC and accounted for 16% (P 0.040), 23% (P 0.019), 45% (P 0.000), 26% (P 0.000), 37% (P 0.001) and 22% (P 0.015), respectively, of the variability in these outcome measures.
No index of adiposity emerged as an independent determinant of fasting or postprandial TG responses. Percentage NEFA suppression (negative) and fasting insulin (positive) together explained 46% (P 0.000) of the variability in fasting TG values, whereas percentage NEFA suppression was the only independent determinant of postprandial TG AUC.
As expected from the highly signi®cant univariate association between fasting TG and percentage LDL-3, fasting TG emerged as a strong independent determinant of this LDL fraction, explaining 47% of the variability in fasting levels (P 0.000).
Discussion
The aim of the present study was to assess relationships between measures of adiposity and fasting and Figure 3 Impact of the apoE genotype on TG vs waist associations. TG, triglycerides; AUC, area under the curve. Tables 1 and 2 . The ®ndings con®rm the previously observed strong positive association between all measures of adiposity and fasting and postprandial insulin response. 34, 35 The higher circulating insulin levels associated with greater fat accumulation appear to have adequately compensated for the loss of insulin sensitivity, since no signi®cant associations between glucose responses and measures of adiposity were evident Ð ®ndings which support the view of other authors. 15,16,36 ± 38 The data also show that the positive association between adiposity and insulin levels largely re¯ects an effect of excess fat mass rather than a speci®c effect of fat distribution, since when the associations for measures of central or subcutaneous fat were corrected for BMI the signi®cant positive relationships between these measures and postprandial insulin and glucose:insulin values no longer remained.
In contrast with most other studies, this study has not found a positive association between BMI or subcutaneous fat accumulation and fasting or postprandial triglyceride responses. We also failed to observe a signi®cant positive association between measures of central adiposity and triglyceride responses; indeed the data indicate a trend towards lower TG response with central adiposity. These ®ndings are directly contrary to most previous studies. 15,16,39 ± 43 The fact that statistical adjustment for BMI had no effect on the relationships suggests that this association is not simply the result of a greater fat mass resulting in greater clearance of circulating TGrich particles. Lack of heterogeneity in the group is a possible, but unlikely, explanation for these observations, since there is clearly suf®cient heterogeneity to demonstrate the expected relationships for insulin and body fat distribution, despite fewer data points for this measure. Furthermore, although the subjects were selected carefully according to metabolic phenotype, they demonstrate a range of anthropometric and TG values which is representative of that which has been reported in studies with other metabolically de®ned groups, such as diabetic patients. 34 Part of the explanation for these ®ndings may be due to the observation that 39% of the ALP group carried an apoE4 allele. This is higher than the prevalence of 25 ± 27% which has been reported in a number of population studies. 44 ± 46 In light of the central role played by apoE in lipoprotein metabolism, 47, 48 it is valid to speculate that apoE genotype may have an impact on adipositymetabolic pro®le associations. Two previous reports based on the same group of overweightamildly obese premenopausal women have reported that in subjects carrying at least one apoE4 allele the expected positive relationships between triglycerides and a centralized fat distribution and insulin and triglyceride responses were not observed. 26, 27 In the current study a lack of positive association between central adiposity and postprandial TG values was more evident in those with an apoE4 genotype relative to the non-E4 carriers. The mechanisms underlying a possible impact of the apoE polymorphism on the association between a centralized fat topography and triglyceride responses remains unclear and warrants further investigation. However, the previously reported higher af®nity of apoE4 for the apoB, E receptor may result in a more rapid catabolism of apoE4-containing TG-rich lipoproteins, 47 which may in part be responsible for the apparent stronger negative association in the E4 group. Nevertheless other explanations may underlie these ®ndings which were observed for the group as a whole, as well as in the apoE4 subjects.
A more controversial explanation for our ®ndings is that, at least for the central fat depots, insulin sensitivity with respect to lipid metabolism may be retained in the ALP so that the greater insulin secretion associated with central fat accumulation, which compensates for any insulin resistance of glucose metabolism, is maladaptive for lipid metabolism. This could result in more effective postprandial processing of chylomicrons (CM) and VLDL through greater activation of the insulin-dependent pathways such as LPL, enhanced re-esteri®cation of released fatty acids in the adipocyte, inhibition of hepatic VLDL production, and a greater postprandial suppression of lipolysis through inhibition of hormone sensitive lipase (HSL) activity. 49 ± 52 This possibility is supported by our observation that insulin emerged as an independent negative determinant of fasting TG levels. This conclusion is also supported by our observation that a more effective early postprandial insulin-induced NEFA suppression (90 min) was associated with a central fat distribution when corrected for the effect of BMI. If resistance to the actions of insulin on lipid metabolism is not the primary determinant of the raised triglycerides in our study population, then this suggests that other factor(s), not measured here may have a greater impact. The question of the comparison of the sensitivities of glucose transport and antilipolysis to insulin in obesity and NIDDM has been addressed in a limited number of studies, 53 ± 56 where quantitative differences in sensitivities have been observed and the lipolytic action of insulin maintained despite a loss of insulin sensitivity with respect to glucose homeostasis. However, further work in this area is needed.
The data and conclusions drawn in the present study are contrary to those of Coulliard et al 16 who found that in two groups of men with similar fat mass but different fat distributions, postprandial TG response was elevated in the group with marked visceral adiposity. 16 This study is worthy of particular note since ALP individuals in the present study had similar fasting lipids characteristics to those of Coulliard et al, apart from the fact that our subjects were characterized as ALP based on criteria which included measurement of LDL-3, which was not measured in the Coulliard study. However, a study conducted by Syvanne et al, 57 which examined the determinants of Attenuated lipaemia and central body fat in ALP AM Minihane et al lipaemia in a group of men with a lipid pro®le and an apoE prevalence similar to our own, found an unexpected negative relationship between BMI and postprandial CM-TG responses. This latter study suggests that our ®ndings are not unique and may be related to the speci®c genetic and lipid pro®le of the group we have investigated who appear highly heterogeneous with respect to the metabolic and genotypic determinants of their raised fasting triglycerides.
A limitation of the present study is that we were unable to use direct measurements of the two fat depots, visceral and subcutaneous fat. Direct imaging techniques such as computerized tomography and magnetic resonance are the most accurate available techniques for measuring total body fat and regional fat distribution. 58, 59 As these techniques were unavailable to us we relied upon indirect measurements of these separate fat depots. However, recent evidence has indicated that waist circumference provides an accurate index of central fat, emerging as the strongest correlate of both the degree of obesity and the accumulation of visceral adipose tissue, when anthropometric data is compared to direct imaging techniques. 60 ± 63 It is of interest that in the present study waist girth also proved to be the measurement which was most consistently associated with the metabolic variables of interest.
In conclusion, the expected associations between indices of body fat and body fat distribution and insulin in individuals with an ALP was observed. The expected associations between triglyceride responses and the percentage LDL in the small dense form and between triglyceride and LPL activity were also seen. However, the expected positive relationship between measures of central adiposity and triglyceride responses was not observed. Although the results indicated that there may be a negative association between lipaemia and central adiposity in those carrying the apoE4 allele, the high prevalence of E4 in the carefully selected ALP group only partly contributes to the observed associations and other contributory factors are undoubtedly involved.
The ®ndings are inconsistent with current understanding of the relationships between insulin resistance, central adiposity and lipaemia, and are not in line with the widely held view that there is a clear causal relationship between insulin resistance, defective TG clearance and elevated postprandial lipaemia in subjects with an ALP. We observed no association between any measures of adiposity and predominance of the key atherogenic particle of the ALP, LDL-3, or between insulin and LDL-3. Further studies are required to identify the metabolic loci responsible for the observed relationship between body fat distribution and triglyceride metabolism in subjects with an ALP, particularly in those with an apoE4 allele.
